Notice Information
Notice Title
NP93420 Rituximab Subcut
Notice Description
Supply of Rituximab Subcut (Mabthera(r)) to NHS Scotland.
Lot Information
Lot 1
The Framework Agreement is for the supply of Rituximab Subcut to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.
Procurement Information
This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000765324
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY504308
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- OJEU - F15 - Voluntary Ex Ante Transparency Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £1,993,338 £1M-£10M
Notice Dates
- Publication Date
- 1 May 20241 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 26 Apr 20241 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Contact Name
- Michelle Semple
- Contact Email
- michelle.semple3@nhs.scot
- Contact Phone
- Not specified
Buyer Location
- Locality
- EDINBURGH
- Postcode
- ML9 2QX
- Post Town
- Motherwell
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM9 Southern Scotland
- Small Region (ITL 3)
- TLM95 South Lanarkshire
- Delivery Location
- TLM Scotland
-
- Local Authority
- South Lanarkshire
- Electoral Ward
- Larkhall
- Westminster Constituency
- Hamilton and Clyde Valley
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY504308
NP93420 Rituximab Subcut - Supply of Rituximab Subcut (Mabthera(r)) to NHS Scotland.
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-r6ebe6-0000765324-2024-05-01T00:00:00Z",
"date": "2024-05-01T00:00:00Z",
"ocid": "ocds-r6ebe6-0000765324",
"initiationType": "tender",
"parties": [
{
"id": "org-26",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "ML9 2QX"
},
"contactPoint": {
"name": "Michelle Semple",
"email": "Michelle.semple3@nhs.scot",
"url": "http://"
},
"roles": [
"buyer"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics"
}
},
{
"id": "org-27",
"name": "Roche Products Ltd",
"identifier": {
"legalName": "Roche Products Ltd"
},
"address": {
"streetAddress": "6 Falcon Way, Shire Park",
"locality": "Welwyn Garden City",
"region": "UK",
"postalCode": "AL7 1TW"
},
"contactPoint": {
"telephone": "+44 01707366171"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-28",
"name": "Sheriff Court House",
"identifier": {
"legalName": "Sheriff Court House"
},
"address": {
"streetAddress": "27 Chambers Street",
"locality": "Edinburgh",
"postalCode": "EH1 1LB"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk",
"telephone": "+44 01312252525",
"url": "http://"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"id": "org-26"
},
"tender": {
"id": "ocds-r6ebe6-0000765324",
"title": "NP93420 Rituximab Subcut",
"description": "Supply of Rituximab Subcut (Mabthera(r)) to NHS Scotland.",
"status": "complete",
"items": [
{
"id": "1",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015",
"mainProcurementCategory": "goods",
"documents": [
{
"id": "MAY504308",
"documentType": "awardNotice",
"title": "NP93420 Rituximab Subcut",
"description": "Supply of Rituximab Subcut (Mabthera(r)) to NHS Scotland.",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY504308",
"format": "text/html"
}
],
"lots": [
{
"id": "1",
"description": "The Framework Agreement is for the supply of Rituximab Subcut to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.",
"status": "complete",
"hasOptions": false
}
],
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"id": "D_OUTSIDE_SCOPE",
"description": "The procurement falls outside the scope of application of the directive"
}
],
"techniques": {
"hasFrameworkAgreement": true
},
"classification": {
"id": "33600000",
"scheme": "CPV"
},
"reviewDetails": "The notification will incorporate a 'standstill period' of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer. The bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
}
},
"awards": [
{
"id": "ocds-r6ebe6-0000765324-1",
"suppliers": [
{
"id": "org-27",
"name": "Roche Products Ltd"
}
],
"relatedLots": [
"1"
]
}
],
"contracts": [
{
"id": "ocds-r6ebe6-0000765324-1",
"awardID": "ocds-r6ebe6-0000765324-1",
"status": "active",
"value": {
"amount": 1993338,
"currency": "GBP"
},
"dateSigned": "2024-04-26T00:00:00Z"
}
],
"language": "EN",
"relatedProcesses": [
{
"id": "1",
"relationship": [
"planning"
],
"scheme": "EU-OJ",
"identifier": "2020/S 131-322242"
}
],
"description": "The estimated value of the Framework Agreement referred to in Section V.2.4 covers the nine (9) month duration of the proposed modification period of the Framework Agreement. NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at http://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=765324. (SC Ref:765324)",
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000765324"
}
],
"noticetype": "OJEU - F15 - Voluntary Ex Ante Transparency Notice"
}